EIF2AK3 and neoplasm: Here, we found that the DNA virus oncoproteins LMP1 and E7 inhibit PERK activity through a conserved DLLC domain, which on the one hand results in tumor progression driven by ROS signaling, but on the other hand, sensitize tumors to chemotherapy possibly via disturbed redox homeostasis.